ZYNERBA

Zynerba is an orphan-focused, neuropsychiatric, biopharmaceutical company taking a different and exciting transdermal approach to cannabinoids... Zynerba Pharmaceuticals has been acquired by Harmony Biosciences, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases. For more information on Harmony and the acquisition, please click here. The RECONNECT clinical trial is ongoing and recruitment remains open. Patients, families and healthcare providers can learn more at FragileXhelp.com.

Also known as: Zynerba Pharmaceuticals, Zynerba Pharmaceuticals, Inc.

Primary location: Devon United States